System Transmission

Top Signal

100#1 JOB

Activity

2190Ripe

+948 today

System

Live1m

Terminal Asset View

stockNASDAQ

OSTX

$1.55+1.97%

OS Therapies Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

46Neutral

Live Analysis Active

Company Mission

OS Therapies Inc creates cancer therapies designed to treat specific types of tumors more effectively. Doctors and patients use these drugs in clinical trials to test if they can extend survival or reduce side effects compared to existing treatments. The company makes money by advancing these therapies through development stages, potentially earning revenue from partnerships, grants, or future drug sales if approved by regulators.

OST

Industry Context

OS Therapies Inc operates in the biotechnology industry, which focuses on developing medical treatments through scientific research. This sector is highly competitive and driven by innovation, with companies often investing heavily in clinical trials to prove their drugs are safe and effective.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

52Matrix

Market Momentum

57.2— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

1.97%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing OSTX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:34 PM UTC

As-of As of 2026-03-15T22:19:29.007Z UTC (~15m delay).

Develops cancer drugs targeting specific tumor types, aiming to improve survival rates and quality of life for patients through clinical trials and potential FDA approvals.

No technical indicators available, so watch for initial price action above any future support level, signaling investor confidence as the company progresses in trials.

No volume data available, but monitor if trading activity increases near key milestones, indicating heightened interest as results or regulatory updates emerge.

Operates in the biotech sector where drug approvals drive value, with price needing to hold above any established low to maintain momentum amid industry volatility.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...